Option to License. Subject to the limitations set forth in this OPTION AGREEMENT, REGENTS grants to OPTIONEE an exclusive, time-limited right to enter into the LICENSE AGREEMENT. OPTIONEE will notify REGENTS promptly, at any time during the term of this OPTION AGREEMENT, if OPTIONEE decides to not exercise the option contained in this OPTION AGREEMENT. Such notice will provide REGENTS with the reason for the decision and will be subject to the Termination by OPTIONEE Article and Notices Article of this OPTION AGREEMENT.
Option to License. Mykrolis grants to MIL a personal, irrevocable, exclusive option for a period of five (5) years from the date of this agreement to elect to obtain a license under one or more of the Mykrolis Optioned Patents (as set forth in Exhibit B). It is contemplated that more than option election may be exercised during this time period. If any such an option is exercised, the license granted shall be personal, irrevocable, exclusive, worldwide, no upfront fee, with a 5% royalty based on Net Sales and non-transferable (except as set forth in Section 8.10) to use the Mykrolis Optioned Patent(s) to make, have made, use, sell or otherwise dispose of Products in the MIL Field of Use.
Option to License. (a) Lipocine hereby grants to Krele the exclusive option (the “Option”) to obtain an exclusive, worldwide license under the Lipocine Intellectual Property (as defined below) for the further development and commercialization of the Product, on the terms and conditions set forth in this Section 3. Krele may elect to exercise the Option by providing Lipocine written notice of such election no later than thirty (30) days after receipt of the Final Report.
Option to License. 4.2.1. NIBRI shall have the exclusive right (the "Option") to license any and all Active Compounds, together with their underlying Myogen Targets or Collaboration Targets, as Development Candidates, for development and commercialization of products with respect to any and all human or veterinary health care uses and any and all agricultural uses, under the terms and conditions set forth in the License Agreement.
Option to License. Should Buyer decide to license any Evaluation Program, Buyer may issue a Contract to this effect, whereupon it will be considered "Licensed Software" and will be subject to the clause entitled "License," along with all of the other terms and conditions of this Agreement, except this clause, as of Seller's acceptance of the Contract.
Option to License. Subject to the terms and conditions of this Agreement, University hereby grants to Company an exclusive option to negotiate an exclusive license to the Technology for a term of six (6) months. The exclusive license will include the right to
Option to License. UTRF, to the extent it is permitted to do so by agreements with sponsors of past or future underlying research and by the provisions of federal law (including, without limitation, Public Laws 96-517 and 98-620), grants to LICENSEE an exclusive option to obtain a license to make, have made, use, market, sell, and import one or more Licensed Products in the Field under the Patent Rights (“Option”). During the term of this Agreement, UTRF shall not negotiate to or offer these rights to any third party.
Option to License. Foundation grants to Sponsor a ninety (90) day option to acquire an exclusive, royalty-bearing license, including the right to sublicense, to Foundation Inventions or Foundation‘s rights in any Joint Inventions. This option period shall commence upon Sponsor’s receipt of Foundation’s Disclosure Notice. The terms of any such royalty-bearing license shall be commercially reasonable and negotiated in good faith by the parties. In the event Sponsor fails to exercise its licensing option within the ninety (90) day option period, Foundation shall not be bound to the terms of the option.
Option to License. (i) Within [**] days of receipt of the disclosure of an Invention, Sponsor will notify Wistar in writing whether Sponsor desires to obtain an Option to License the Invention and any Wistar Background Technology. If Sponsor does not notify Wistar of its desire to obtain an Option to License such Invention within such time frame, Sponsor will have no further rights in such disclosed Invention. Wistar/OncoCyte Sponsored Research Agreement Certain information has been omitted under a request for confidential treatment, and the omitted information has been filed with the Commission. Confidential portions are marked [**].
Option to License. (i) Institute hereby grants to Sponsor an exclusive option to negotiate an exclusive, worldwide, royalty-bearing commercial license to all of Institute’s interest and rights in any Improvement(s) or Other Invention(s) (and related patent rights), which license would, unless otherwise agreed in writing by the parties, be implemented by adding the patent rights to the Improvements to the Exclusive License Agreement between the parties dated February , 2014 (“ELA”). This option must be exercised within [***] from the end of the research term for the applicable Research Plan. If the research term is not stated in a Research Plan, then the research term ends for each Research Plan on delivery of the final report for the Research conducted under the Research Plan. Sponsor may exercise its option for any Improvement or Other Invention, such Improvement to Sponsor by Sponsor notifying Institute’s Vice President of Research in writing. Following exercise of the option for one or more particular Improvement(s) or Other Invention(s), Sponsor and Institute shall negotiate in good faith terms for a license on commercially reasonable terms to such Improvement(s) or Other Invention(s) within [***], which terms shall be consistent with the following, as applicable:
